Section Editor: Joseph V. Lombardi, MD, FACS, Chief of Vascular and Endovascular Surgery and Professor of Surgery, Cooper Medical School of Rowan University, Camden, NJ; Director of the Cooper Aortic Center
Constantino S. Peña, MD, interventional radiologist at the Miami Cardiac and Vascular Institute, presented several sessions at SIR, including one on this topic. VDM spoke with Dr. Pena about his presentation.
Constantino S. Peña, MD, interventional radiologist at the Miami Cardiac and Vascular Institute, presented several sessions at SIR, including one on this topic. VDM spoke with Dr. Pena about his presentation.
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment.
FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment.
FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...
Nikolaos Tsilimparis, MD
University Hospital of Munich, Germany
Nikolaos Tsilimparis, MD
University H...
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
Department of Vascular Surgery, Army Hospital Research & Referral, New Delhi, India
Jha Manvendu, DrNB; G. Keshavamurthy,...
A 74-year-old man, who was a chronic smoker with a known case of hypertension and chronic obstructive pulmonary disease, presented with a history of breathlessness on minimal exertion.
A 74-year-old man, who was a chronic smoker with a known case of hypertension and chronic obstructive pulmonary disease, presented with a history of breathlessness on minimal exertion.
MDR CE mark approval signifies the first off-theshelf single-branch thoracic endoprosthesis for patients requiring zone 2 treatment.
PUTZBRUNN, GERMANY (February 1, 2024) — W. L. Gore & Associates, Inc. (Gore) today announced the first...
MDR CE mark approval signifies the first off-theshelf single-branch thoracic endoprosthesis for patients requiring zone 2 treatment.
PUTZBRUNN, GERMANY (February 1, 2024) — W. L. Gore & Associates, Inc. (Gore) today announced the first...
With improvements to the stent graft delivery system enabling a 1 Fr profile reduction
on the majority of sizes, the device now offers the most 6 Fr compatible configurations among balloon expandable stent grafts.
FLAGSTAFF, Ariz....
With improvements to the stent graft delivery system enabling a 1 Fr profile reduction
on the majority of sizes, the device now offers the most 6 Fr compatible configurations among balloon expandable stent grafts.
FLAGSTAFF, Ariz....
Darren Schneider, MD National Principal Investigator, U.S. IDE Clinical Trial
Darren Schneider, MDNational Principa...
Watch as Dr. Darren Schneider discusses impact to perceptions on whether to sacrifice or preserve the hypogastric artery based on key outcomes from 5-year IDE data.
Watch as Dr. Darren Schneider discusses impact to perceptions on whether to sacrifice or preserve the hypogastric artery based on key outcomes from 5-year IDE data.
Gary Ansel, MD; Sean Lyden, MD; Lucas Ferrer Cardona, MD; Dean Ferrera, DO
Gary Ansel, MD; Sean Lyden, MD; Lucas...
Gary Ansel, MD, Sean Lyden, MD, Lucas Ferrer Cardona, MD and Dean Ferrera, DO describe the impact of the Pounce™ Thrombectomy System on the removal of peripheral arterial thrombi and emboli.
Gary Ansel, MD, Sean Lyden, MD, Lucas Ferrer Cardona, MD and Dean Ferrera, DO describe the impact of the Pounce™ Thrombectomy System on the removal of peripheral arterial thrombi and emboli.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Join Dr. Ripal Gandhi and Dr. Neal Viradia as they discuss how the PRESERVE data impacted their filter placements and retrievals and how Option ELITE provides the safety, retrievability and versatility they look for in an IVC filter.
Join Dr. Ripal Gandhi and Dr. Neal Viradia as they discuss how the PRESERVE data impacted their filter placements and retrievals and how Option ELITE provides the safety, retrievability and versatility they look for in an IVC filter.
Marianne Brodmann, MD
Medical University of Graz, Graz, Austria
Marianne Brodmann, MD
Medical Univers...
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Purpose: To describe a case of an endovascular repair of a ruptured infected thoracic aortic aneurysm and to provide a review of the current literature involving treatment.
Purpose: Endoleaks, which are a common complication after endovascular aneurysm repair (EVAR), result from retrograde blood flow into the aneurysm sac.
Purpose: Endoleak is the most common complication after endovascular aneurysm repair (EVAR). Endoleak is often asymptomatic and is associated with an increased risk of poor outcomes. The ...
Purpose: To determine the safety and feasibility of filling an abdominal aortic aneurysm (AAA) sac with a novel, bioabsorbable embolic device at the time as endovascular aneurysm repair (...
Purpose: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a minimally invasive technique used to control aortic hemorrhage in patients experiencing profound shock. REB...
Purpose: Surgery of the thoracic aorta leads to high mortality and morbidity rates. The endovascular technique has enjoyed greater permissiveness for the treatment of penetrating ulcer, i...
Purpose: We aim to illustrate a rare case of a peripheral artery pseudoaneurysm secondary to pulmonary infection that underwent successful treatment with coil embolization. We will discus...
Purpose: To evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device in patients undergoing percutaneous endovascular abdominal aortic aneurysm repair (PEVA...
Purpose: This presentation includes a pictorial review of aortic endoleaks by type, discusses surveillance strategies and imaging modalities, and provides optimal treatment strategies for...
Kailin Opella, Andrew Ibrahim, Vivie Tran, Annmarie Farag, Minnie Tran, Mohammad Ansari
PAD Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, Texas
Introducti...
Subash Swarna, Seena Firouzbakht, Vivie Tran, Amber Hernandez, Hoang Ho, Leigh A. Jenkins, MD, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences Cen...
Vivie Tran, Alistair Disraeli, Nate Fernandez, Karter Morris, Hoang Ho, Dixon Santana, MD, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences Center, ...
Vivie Tran, Hoang Ho, Steven Daley, Simon Williams, MD, Aliakbar Arvandi, MD, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, ...
Vivie Tran, Hoang Ho, Subash Swarna, Andrew Ibrahim, Minnie Tran, Steven Daley, Simon Williams, MD, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences...
Sachi Khemka, Hannah Seo, Vivie Tran, Kailin Opella, Esther Burns, Hoang Ho, Marina Iskandir, MD, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences C...
Vivie Tran, Daniel Xue, Sachi Khemka, Hoang Ho, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, USA
Andrew Ibrahim, Mohamad Altabaa, Zeba Momin, Maryam Niazi, Anthony Bruccoliere, Hoang Ho, Annmarie Farag, Dixon Santana, MD, Mohammad (Mac) Ansari, MD
PAD Center of Excellence, Texas Tec...
Andrew Ibrahim, Caroline Cushman, Mitchell DeVolder, Hoang Ho, Annmarie Farag, Dixon Santana, MD, Mohammad (Mac) Ansari, MD
PAD Center of Excellence, Texas Tech University Health Science...
A. Powell, T. Maldonado, K. Nagarsheth, J. Rowse, J. Chung
A. Powell, T. Maldonado, K. Nagarshet...
Purpose: In a recent meta-analysis, the reported rate of 30-day limb salvage in patients with acute limb ischemia (ALI) after surgical intervention was 83.1%. The purpose of this interim analysis is to report safety and performance data from...
Purpose: In a recent meta-analysis, the reported rate of 30-day limb salvage in patients with acute limb ischemia (ALI) after surgical intervention was 83.1%. The purpose of this interim analysis is to report safety and performance data from...
Nikolaos Tsilimparis, MD
University Hospital of Munich, Germany
Nikolaos Tsilimparis, MD
University H...
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
Erasmus University Medical Center, Rotterdam, the Netherlands
Hence Verhagen, MD
Erasmus Universit...
An important head-to-head RCT of 2 leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
An important head-to-head RCT of 2 leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
Presented by Ramon Varcoe, MBBS, MS, PhD, MMed (ClinEpi), Prince of Wales Hospital, Sydney, Australia
Written by Amanda Wright Harvey
Pres...
According to Dr. Ramon L. Varcoe at ISET 2023, the aim of his study was to use linked clinical registries and administrative data to investigate the primary endpoint—differences in long-term all-cause mortality between contemporary EVAR...
According to Dr. Ramon L. Varcoe at ISET 2023, the aim of his study was to use linked clinical registries and administrative data to investigate the primary endpoint—differences in long-term all-cause mortality between contemporary EVAR...
Presented by Zvonomir Kracjer, MD, FACC, Texas Heart Institute and Luke’s Medical Center, Baylor College of Medicine, Houston, Texas
Presented by Zvonomir Kracjer, MD, FA...
A Tuesday session on large vessel closure was presented by Dr. Zvonomir Kracjer of the Texas Heart Institute and Luke’s Medical Center in Houston, Texas. Dr. Kracjer began with a review of large vessel closure devices (VCDs) approved for...
A Tuesday session on large vessel closure was presented by Dr. Zvonomir Kracjer of the Texas Heart Institute and Luke’s Medical Center in Houston, Texas. Dr. Kracjer began with a review of large vessel closure devices (VCDs) approved for...
Presented by Marc Schermerhorn, MD, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Presented by Marc Schermerhorn, MD, H...
During Tuesday's Aortic Update session, Dr. Marc Schermerhorn from Harvard Medical School and Beth Israel Deaconess Medical Center in Boston, Massachusetts, gave a presentation on sac shrinkage in endovascular aneurysm repair (EVAR). He began...
During Tuesday's Aortic Update session, Dr. Marc Schermerhorn from Harvard Medical School and Beth Israel Deaconess Medical Center in Boston, Massachusetts, gave a presentation on sac shrinkage in endovascular aneurysm repair (EVAR). He began...
Presented by John Fritz Angle, MD, University of Virginia, Charlottesville, Virginia
Presented by John Fritz Angle, MD, Un...
During Tuesday’s session on Aortic Updates, Dr. John Fritz Angle of the University of Virginia in Charlottesville provided an overview on managing branch vessels in acute dissections.
During Tuesday’s session on Aortic Updates, Dr. John Fritz Angle of the University of Virginia in Charlottesville provided an overview on managing branch vessels in acute dissections.
Presented by Frank Arko, III, MD, Sanger Heart & Vascular Institute, Charlotte, North Carolina
Presented by Frank Arko, III, MD, San...
During Monday morning’s focused symposium on Essentials of Endovascular Therapy, Dr. Frank Arko began his presentation on aorto-iliac disease by discussing the role of endovascular therapy in TASC II C and D inflow disease.
During Monday morning’s focused symposium on Essentials of Endovascular Therapy, Dr. Frank Arko began his presentation on aorto-iliac disease by discussing the role of endovascular therapy in TASC II C and D inflow disease.
Presented by George Vatakencherry, MD, FSIR, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
Presented by George Vatakencherry, MD...
During Monday morning’s focused symposium on Essentials of Endovascular Therapy, Dr. George Vatakencherry discussed the evaluation and treatment of abdominal aortic aneurysms.
During Monday morning’s focused symposium on Essentials of Endovascular Therapy, Dr. George Vatakencherry discussed the evaluation and treatment of abdominal aortic aneurysms.
Robert Lookstein, MD
Icahn School of Medicine at Mount Sinai, New York, New York
Robert Lookstein, MD
Icahn School of ...
The future of venous thrombosis treatment was tackled in a VIVA@LINC session on Wednesday afternoon by Robert Lookstein, MD, Professor of Radiology and Surgery at the Icahn School of Medicine at Mount Sinai in New York City.
The future of venous thrombosis treatment was tackled in a VIVA@LINC session on Wednesday afternoon by Robert Lookstein, MD, Professor of Radiology and Surgery at the Icahn School of Medicine at Mount Sinai in New York City.
Nikolaos Tsilimparis, MD
University Hospital of Munich, Germany
Nikolaos Tsilimparis, MD
University H...
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
Tatsuya Nakama, MD
Tokyo Bay Medical Center, Japan
Tatsuya Nakama, MD
Tokyo Bay Medical ...
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The latest results from the LUMIFOLLOW trial—a prospective, multicenter, consecutive, post-market study of the Luminor drug-eluting balloon (DCB; iVascular) in the treatment of femoropopliteal lesions—was discussed by Eric Ducasse, Professor...
The latest results from the LUMIFOLLOW trial—a prospective, multicenter, consecutive, post-market study of the Luminor drug-eluting balloon (DCB; iVascular) in the treatment of femoropopliteal lesions—was discussed by Eric Ducasse, Professor...
Ralf Langhoff
Sankt Gertrauden-Krankenhaus, Berlin, Germany
Ralf Langhoff
Sankt Gertrauden-Kranke...
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Tim Wittig, MD
University Hospital Leipzig, Germany
Tim Wittig, MD
University Hospital Le...
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
Oliver Schlager, MD
Medical University of Vienna, Austria
Oliver Schlager, MD
Medical Universit...
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.
Peter A. Schneider, MD
University of California, San Francisco
Peter A. Schneider, MD
University of ...
“Concepts, techniques, tools, goals of care—all of that’s changed dramatically with regards to catheter-based treatments for lower extremity revascularization over the last 20 years,” said Dr. Peter Schneider.
“Concepts, techniques, tools, goals of care—all of that’s changed dramatically with regards to catheter-based treatments for lower extremity revascularization over the last 20 years,” said Dr. Peter Schneider.
Lorenzo Patrone, MD
West London Vascular and Interventional Centre, London, UK
Lorenzo Patrone, MD
West London Vascu...
At LINC, Dr Patrone discussed a new project based on the Sentante, a fully robotic teleoperated system for endovascular interventions that has been created by UAB Inovatyvi Medicina (Kaunas, Lithuania).
At LINC, Dr Patrone discussed a new project based on the Sentante, a fully robotic teleoperated system for endovascular interventions that has been created by UAB Inovatyvi Medicina (Kaunas, Lithuania).
Manuela Konert, MD
University Hospital Leipzig, Germany
Manuela Konert, MD
University Hospita...
The case for mechanical thrombectomy as a means to eliminate post-thrombotic syndrome (PTS) was discussed today by Manuela Konert, a consultant interventionalist and head of the venous centre at University Hospital Leipzig, Germany.
The case for mechanical thrombectomy as a means to eliminate post-thrombotic syndrome (PTS) was discussed today by Manuela Konert, a consultant interventionalist and head of the venous centre at University Hospital Leipzig, Germany.
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment.
FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment.
FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
MDR CE mark approval signifies the first off-theshelf single-branch thoracic endoprosthesis for patients requiring zone 2 treatment.
PUTZBRUNN, GERMANY (February 1, 2024) — W. L. Gore & Associates, Inc. (Gore) today announced the first...
MDR CE mark approval signifies the first off-theshelf single-branch thoracic endoprosthesis for patients requiring zone 2 treatment.
PUTZBRUNN, GERMANY (February 1, 2024) — W. L. Gore & Associates, Inc. (Gore) today announced the first...
With improvements to the stent graft delivery system enabling a 1 Fr profile reduction
on the majority of sizes, the device now offers the most 6 Fr compatible configurations among balloon expandable stent grafts.
FLAGSTAFF, Ariz....
With improvements to the stent graft delivery system enabling a 1 Fr profile reduction
on the majority of sizes, the device now offers the most 6 Fr compatible configurations among balloon expandable stent grafts.
FLAGSTAFF, Ariz....
The GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis approval brings the first branched, all-in-one solution for patients with thoracoabdominal aortic aneurysms and high-surgical risk patients with pararenal aortic aneurysms in patients...
The GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis approval brings the first branched, all-in-one solution for patients with thoracoabdominal aortic aneurysms and high-surgical risk patients with pararenal aortic aneurysms in patients...
Trial to randomize 400 subjects at multiple sites, primarily in the U.S., to evaluate safety and efficacy of the investigational Nectero EAST System for treatment of infrarenal AAA, maximum diameter 3.5-5.0cm
TEMPE, Ariz., January 18,...
Trial to randomize 400 subjects at multiple sites, primarily in the U.S., to evaluate safety and efficacy of the investigational Nectero EAST System for treatment of infrarenal AAA, maximum diameter 3.5-5.0cm
TEMPE, Ariz., January 18,...
CAUTION: Investigational device. Limited by United States law to investigational use.
The first patient implant in the ARISE II Pivotal Study evaluation of the GORE® Ascending Stent Graft represents a major milestone in the development of...
CAUTION: Investigational device. Limited by United States law to investigational use.
The first patient implant in the ARISE II Pivotal Study evaluation of the GORE® Ascending Stent Graft represents a major milestone in the development of...
HOUMA, LA - Cardiovascular Institute of the South (CIS) is the first in Louisiana to use the latest generation of Medtronic's self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut FX, designed to enhance ease-of-use...
HOUMA, LA - Cardiovascular Institute of the South (CIS) is the first in Louisiana to use the latest generation of Medtronic's self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut FX, designed to enhance ease-of-use...
Rosemont, Ill., January 24, 2022 – A review evaluating the results of thoracic endovascular aortic repair (TEVAR) following acute type B aortic dissection (aTBAD) suggests most patients with aTBAD have less than 2 cm of proximal healthy...
Rosemont, Ill., January 24, 2022 – A review evaluating the results of thoracic endovascular aortic repair (TEVAR) following acute type B aortic dissection (aTBAD) suggests most patients with aTBAD have less than 2 cm of proximal healthy...
Whether treating a potentially fatal, fast-moving aortic dissection, or long-term, slowly developing issue with the largest blood vessel in the body, specialists at the new Beaumont Aortic Center treat complex aortic disease with the most...
Whether treating a potentially fatal, fast-moving aortic dissection, or long-term, slowly developing issue with the largest blood vessel in the body, specialists at the new Beaumont Aortic Center treat complex aortic disease with the most...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.